Provides recommendations for the statistical analysis of dog telemetry studies used in regulatory cardiovascular safety assessments.
Expert recommendations on dog telemetry analysis merit review by safety pharmacologists; leaves open empirical confirmation in diverse regulatory settings.
In 2008, the PSI Toxicology Special Interest Group met to discuss the design and analysis of dog telemetry studies. The dog telemetry study is one component of the integrated cardiovascular assessment required by regulatory bodies. Although there are guidelines for these studies, little is said about the statistical analysis. With parameters of interest measured continually over time, in studies typically involving four dogs, the analysis is not straightforward. This has led to many different types of analysis being proposed in the literature, with many different methods applied within the pharmaceutical industry itself. This paper summarizes the PSI Toxicology group's discussions and recommendations around these issues.
No takes yet. Share an insight, caveat, or question.
Aylott et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Pharmaceutical Statistics